Literature DB >> 15513313

Cardioprotection afforded by ischemic preconditioning interferes with chronic beta-blocker treatment.

Yoshihiro Suematsu1, Vesa Anttila, Shinichi Takamoto, Pedro del Nido.   

Abstract

OBJECTIVES: The efficacy of ischemic preconditioning of the heart has remained controversial. We investigated whether chronic treatment with beta-blockers affects the ischemic preconditioning in the isolated rat heart model.
DESIGN: Wistar rats were treated with propranolol (50 mg/kg/day, p.o.) (PRL), with nipradilol (10 mg/kg/day, p.o.) (NPL), or with vehicle, for 4 weeks. Isolated rat hearts were divided into global ischemia hearts (GI, PRL and NPL, each n=6) and ischemic preconditioned hearts (IP, PRL+IP and NPL+IP, each n=6).
RESULTS: Significant differences in left ventricular pressure were observed between the PRL and PRL+IP, and between the NPL and NPL+IP groups. In the NPL group, significant amelioration and preservation of left ventricular peak pressure, coronary flow, reduction of infarct size, and NOx preservation were observed. Lipid peroxidation in the NPL group was significantly reduced before and after global ischemia compared to the GI group.
CONCLUSIONS: The effect of ischemic preconditioning was abolished in the hearts of rats following oral treatment of propranolol or nipradilol. However, the administration of nipradilol protected the ischemic and reperfused myocardium, partly due to the prevention of lipid peroxide formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15513313     DOI: 10.1080/14017430410021507

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  7 in total

Review 1.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 2.  Impact of hypoglycemic agents on myocardial ischemic preconditioning.

Authors:  Rosa Maria Rahmi Garcia; Paulo Cury Rezende; Whady Hueb
Journal:  World J Diabetes       Date:  2014-06-15

3.  Chronic β1-adrenoceptor blockade impairs ischaemic tolerance and preconditioning in murine myocardium.

Authors:  Louise E See Hoe; Jan M Schilling; Anna R Busija; Kristofer J Haushalter; Victoria Ozberk; Malik M Keshwani; David M Roth; Eugene Du Toit; John P Headrick; Hemal H Patel; Jason N Peart
Journal:  Eur J Pharmacol       Date:  2016-06-30       Impact factor: 4.432

4.  Unique transcriptional profile of sustained ligand-activated preconditioning in pre- and post-ischemic myocardium.

Authors:  Kevin J Ashton; Amanda Tupicoff; Grant Williams-Pritchard; Can J Kiessling; Louise E See Hoe; John P Headrick; Jason N Peart
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

Review 5.  Perioperative Cardioprotection by Remote Ischemic Conditioning.

Authors:  Youn Joung Cho; Won Ho Kim
Journal:  Int J Mol Sci       Date:  2019-09-29       Impact factor: 5.923

Review 6.  Acute Stress Decreases but Chronic Stress Increases Myocardial Sensitivity to Ischemic Injury in Rodents.

Authors:  Eric D Eisenmann; Boyd R Rorabaugh; Phillip R Zoladz
Journal:  Front Psychiatry       Date:  2016-04-25       Impact factor: 4.157

7.  Sevoflurane, Propofol and Carvedilol Block Myocardial Protection by Limb Remote Ischemic Preconditioning.

Authors:  Youn Joung Cho; Karam Nam; Tae Kyong Kim; Seong Woo Choi; Sung Joon Kim; Derek J Hausenloy; Yunseok Jeon
Journal:  Int J Mol Sci       Date:  2019-01-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.